RecruitingNot Applicable

A Mobile Brain/Body Imaging Platform for the Assessment and Optimization of Post-stroke Overground Robotic Gait Treatments

Italy30 participantsStarted 2025-05-06

Plain-language summary

The study aims to identify neural biomarkers that can be used to monitor the recovery of locomotion and movement of post-stroke patients, both in natural settings and with enriched treatment using robotic device. These biomarkers could potentially be utilized in clinical practice to improve recovery outcomes. Additionally, the study seeks to investigate whether it is feasible to use these biomarkers to predict the extent of recovery that patients may achieve.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥18 years old * Stroke patients with different etiology: ischemic or hemorrhagic * Able to walk independently, eventually with aids/orthosis (FAC\>2) * Able to give the informed consent and to comprehend the instructions necessary to complete the task * Subject's anthropometric parameters adequate to wear the exoskeleton; * Body weight \< 90 kg; * Height 150 ÷ 192 cm; * Thigh lenght: 355 ÷ 475 mm; * Calf lenght: 405 ÷ 485 mm; * Hip width : 690 ÷ 990 mm; Exclusion Criteria: * Incapacity to give the informed consent and understand the tasks required * Fixed contracture at lower limbs that limits the use of the exoskeleton * Incapacity to walk independently (FAC\<=2) * Subject's anthropometric parameters not adequate to wear the exoskeleton

What they're measuring

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor outcome measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor oucome measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Trial details

NCT IDNCT07510633

SponsorDr. Franco Molteni

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-05

Contact for this trial

Franco Molteni, MD

+39 031 8544219 fmolteni@valduce.it

View on ClinicalTrials.gov More Stroke trials

Plain-language summary

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor outcome measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor Outcome Measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up

Motor oucome measure

Timeframe: From enrollment to the end of treatment at 4 weeks + 4 weeks follow-up